lncRNA JPX modulates malignant progress of osteosarcoma through targeting miR-33a-5p and PNMA1 regulatory loop

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Osteosarcoma (OS) is a prevalent bone tumor with high metastatic potential.
• Current cancer therapies lack effective strategies to curb OS metastasis.
• Understanding OS carcinogenesis mechanisms is crucial for developing new treatments.

Purpose of the Study:

• Investigate the role of long noncoding RNA JPX (lncRNA JPX) in osteosarcoma.
• Elucidate the molecular mechanisms underlying JPX's function in OS progression.

Main Methods:

• Quantitative real-time PCR to measure lncRNA JPX expression in OS tissues and cells.
• siRNA-mediated knockdown of JPX to assess its functional impact.
• In vitro assays to evaluate cell proliferation, migration, and invasion.
• MiRNA sponge assays to determine interactions between JPX and miR-33a-5p.
• Western blotting to assess protein expression levels.

Main Results:

• lncRNA JPX was significantly upregulated in OS tissues and cells.
• JPX knockdown suppressed OS cell proliferation, migration, and invasion.
• JPX functioned as a molecular sponge for miR-33a-5p, mediating its effects on OS cells.
• Downregulation of miR-33a-5p led to PNMA1 upregulation, which promoted OS cell proliferation, migration, and invasion.

Conclusions:

• lncRNA JPX plays a critical role in promoting osteosarcoma cell proliferation, migration, and invasion.
• The JPX/miR-33a-5p/PNMA1 axis is a key regulatory pathway in OS.
• lncRNA JPX represents a potential therapeutic target for osteosarcoma treatment.